Literature DB >> 8571330

The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.

R Kumar1, S Béguin, H C Hemker.   

Abstract

We tested different types of clot for their ability to provoke procoagulant activity in platelets: normal clots from platelet poor plasma (des AABB- or fibrin II clots), similar clots in which the adsorbed thrombin has been inhibited by hirudin, and clots obtained by the action of two snake venom enzymes that release only fibrinopeptide A (des AA- or fibrin I clots). Analogous clots from fibrinogen solutions were also tested. In platelet rich plasma (PRP), where platelet coagulant phospholipids (PCP) are rate limiting for thrombin generation, the addition of any type of clot enhances the generation of thrombin thus it induces the appearance of PCP. Clots containing active adsorbed thrombin are the most potent ones in this respect. Lactate dehydrogenase (LDH) levels do not increase in the course of the thrombin generation so the platelets are not damaged in the process. Non-centrifugable PCP could be demonstrated to appear during the process, so the production of procoagulant phospholipid microparticles must be part of the mechanism. Membrane transbilayer phosphatidyl serine movement (flip-flop) can not be demonstrated in PRP as the activated platelets are caught in the emerging clot. In order to demonstrate flip-flop, we tried to investigate the influence of clots on washed platelets. However, contrary to platelets in a plasma milieu, isolated platelets are damaged by fibrin clots, especially in the presence of thrombin, as can be judged from the appearance of LDH. We conclude that, in PRP, clots induce the appearance of PCP from platelets by vesiculation, possibly accompanied by flip-flop and that thrombin accelerates the process but is not an absolute requirement.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8571330

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  16 in total

1.  Role of clot-associated (-derived) thrombin in cell proliferation induced by fibrin clots in vitro.

Authors:  E Gandossi; C Lunven; C N Berry
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

2.  Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the gamma'-chain.

Authors:  Trang T Vu; Alan R Stafford; Beverly A Leslie; Paul Y Kim; James C Fredenburgh; Jeffrey I Weitz
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

3.  Anticoagulation by factor Xa inhibitors.

Authors:  T Orfeo; S Butenas; K E Brummel-Ziedins; M Gissel; K G Mann
Journal:  J Thromb Haemost       Date:  2010-05-21       Impact factor: 5.824

Review 4.  Tissue factor in coagulation: Which? Where? When?

Authors:  Saulius Butenas; Thomas Orfeo; Kenneth G Mann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-10       Impact factor: 8.311

Review 5.  Thrombin generation, fibrin clot formation and hemostasis.

Authors:  Alisa S Wolberg; Robert A Campbell
Journal:  Transfus Apher Sci       Date:  2008-02-20       Impact factor: 1.764

6.  Predictors of Thromboembolic Events in Patients with Ventricular Assist Device.

Authors:  Amelia K Boehme; Salpy V Pamboukian; James F George; Chrisly Dillon; Emily B Levitan; Russell Griffin; T Mark Beasley; Gerald McGwin; James K Kirklin; Nita A Limdi
Journal:  ASAIO J       Date:  2015 Nov-Dec       Impact factor: 2.872

Review 7.  Prevention of venous thromboembolism following orthopaedic surgery: clinical potential of direct thrombin inhibitors.

Authors:  Bengt I Eriksson; Ola E Dahl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

8.  Biophysical characterization of anticoagulant hemextin AB complex from the venom of snake Hemachatus haemachatus.

Authors:  Yajnavalka Banerjee; Rajamani Lakshminarayanan; Subramanian Vivekanandan; Ganesh Srinivasan Anand; Suresh Valiyaveettil; R Manjunatha Kini
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

9.  The nature of the stable blood clot procoagulant activities.

Authors:  Thomas Orfeo; Kathleen E Brummel-Ziedins; Matthew Gissel; Saulius Butenas; Kenneth G Mann
Journal:  J Biol Chem       Date:  2008-02-11       Impact factor: 5.157

Review 10.  Fibrinolysis in Platelet Thrombi.

Authors:  Rahim Kanji; Ying X Gue; Vassilios Memtsas; Diana A Gorog
Journal:  Int J Mol Sci       Date:  2021-05-12       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.